Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Dauge

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Pharmacology, Biochemistry, and Behavior|February 1, 1995
CCKA, but not CCKB, agonists suppress the hyperlocomotion induced by endogenous enkephalins, protected from enzymatic degradation by systemic RB 101V Dauge, P J Corringer, B P Roques
European Journal of Pharmacology|September 11, 1987
Use of mu and delta opioid peptides of various selectivity gives further evidence of specific involvement of mu opioid receptors in supraspinal analgesia (tail-flick test)V Dauge, F Petit, P Rossignol, et al.
Peptides|September 1, 1990
Synthesis, biochemical and pharmacological properties of BUBUC, a highly selective and systemically active agonist for in vivo studies of delta-opioid receptorsG A Gacel, E Fellion, A Baamonde, et al.
Therapie|November 1, 1992
[Study of induced effects by selective CCKB agonists cholecystokinin in the nociception and behavior in rodents]V Dauge, M Derrien, C Durieux, et al.
Synapse (New York, N.Y.)|January 1, 1990
Investigation of behavioral and electrophysiological responses induced by selective stimulation of CCKB receptors by using a new highly potent CCK analog, BC 264V Dauge, G A Bohme, J N Crawley, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Pharmacology, Biochemistry, and Behavior|February 1, 1995
CCKA, but not CCKB, agonists suppress the hyperlocomotion induced by endogenous enkephalins, protected from enzymatic degradation by systemic RB 101V Dauge, P J Corringer, B P Roques
European Journal of Pharmacology|September 11, 1987
Use of mu and delta opioid peptides of various selectivity gives further evidence of specific involvement of mu opioid receptors in supraspinal analgesia (tail-flick test)V Dauge, F Petit, P Rossignol, et al.
Peptides|September 1, 1990
Synthesis, biochemical and pharmacological properties of BUBUC, a highly selective and systemically active agonist for in vivo studies of delta-opioid receptorsG A Gacel, E Fellion, A Baamonde, et al.
Therapie|November 1, 1992
[Study of induced effects by selective CCKB agonists cholecystokinin in the nociception and behavior in rodents]V Dauge, M Derrien, C Durieux, et al.
Synapse (New York, N.Y.)|January 1, 1990
Investigation of behavioral and electrophysiological responses induced by selective stimulation of CCKB receptors by using a new highly potent CCK analog, BC 264V Dauge, G A Bohme, J N Crawley, et al.
Pageof 1